(Q44634372)

English

Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Factors associated with early termination of CHOP therapy and the impact on survival among patients with chemosensitive intermediate-grade non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Elizabeth A Chrischilles

object named as

Elizabeth A Chrischilles

1

0 references

object named as

Brian K Link

2

0 references

author name string

Shane D Scott

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

David J Delgado

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Moshe Fridman

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

396-403

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000507

21 January 2018

Identifiers

10.1177/107327480301000507

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44634372&oldid=2029792697"